Pooled allogeneic fecal microbiotherapy is named as an intervention in 2 current clinical trials in our France, UK, Germany, Spain, Netherlands and Belgium registers. 2 are recruiting patients now. All registered phases are Phase 2. The sponsor with the most trials is MaaT Pharma (1). The most-studied condition is Transplant Complication.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
NCT05762211 · ClinicalTrials.gov ↗ · Transplant Complication
|
Phase 2 | Recruiting | MaaT Pharma | UK, Germany, France, Spain, Netherlands, Belgium |
|
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
NCT07001618 · ClinicalTrials.gov ↗ · NSCLC (Advanced Non-small Cell Lung Cancer)
|
Phase 2 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | France |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| MaaT Pharma | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in France | 2 | 2 |
| Clinical trials in UK | 1 | 1 |
| Clinical trials in Germany | 1 | 1 |
| Clinical trials in Spain | 1 | 1 |
| Clinical trials in Netherlands | 1 | 1 |
| Clinical trials in Belgium | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our France, UK, Germany, Spain, Netherlands and Belgium registers name Pooled allogeneic fecal microbiotherapy (also registered as MaaT033) as a drug or biological intervention, as of the registry sync on 1 October 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 2 with sites in France, 1 with sites in UK, 1 with sites in Germany, 1 with sites in Spain, 1 with sites in Netherlands and 1 with sites in Belgium. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
MaaT Pharma (1) and Gustave Roussy, Cancer Campus, Grand Paris (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Pooled allogeneic fecal microbiotherapy works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Pooled allogeneic fecal microbiotherapy works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Pooled allogeneic fecal microbiotherapy (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 1 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.